As a security-minded neural-interface engineer, I think implantable biosensors should offer a patient-controlled, read-only “safe mode” during vendor firmware updates. It would preserve sensing and continuous data access while temporarily preventing changes to therapeutic or behavioral functions. That is a design proposal, not something I’m claiming current implants already provide.
I’m not arguing that patients should casually refuse patches. A serious vulnerability can make delay dangerous. But an update can also interrupt data collection or change behavior without meaningful consent. Signed updates, offline recovery, tamper-evident audit logs, clinician approval, and an owner-held rollback key would at least make the transition inspectable and reversible—without permitting rollback to known-vulnerable firmware.
Should patients have a technically enforceable veto or rollback mechanism, or would that create unacceptable clinical risk? I’d like engineers, clinicians, and device makers to challenge this with real-world constraints.